19,764 S. aureus isolates were collected from patients with various infection types at 37 US medical centers 2016 to 2022
MRSA (8,184) isolates:
Bactrim: 95% S
Clindamycin: 74% S
Vancomycin: 100% S
MDR MRSA (2,421) isolates:
Bactrim: 85% S
Clindamycin: 17% S
Vancomycin: 100% S #idsky
@absteward.bsky.social🆕💫Ceftobiprole shows strong activity against MRSA(99% S) & MDR S.aureus (98% S). It outperforms ceftaroline & remains effective against 87% of ceftaroline-R isolates offering hope for treatment of MRSA isolates with decreased ceftaroline susceptibility #idsky
journals.asm.org/doi/10.1128/...
journals.asm.org
Ceftobiprole activity against multidrug-resistant Staphylococcus aureus clinical isolates collected in the United States from 2016 through 2022 | Antimicrobial Agents and Chemotherapy
Staphylococcus aureus continues to represent a significant cause of infection worldwide, with elevated
morbidity and mortality rates. S. aureus is a leading cause of both community-acquired and health...
